Maquet buys LAA closure device developer
Candace Stuart | May 21, 2013 | Cardiovascular Business | Heart Rhythm

Maquet Cardiovascular has acquired LAAx, the developer of an implantable left atrial appendage (LAA) closure device.

LAAx makes the TigerPaw System II, a mechanical occlusion device that is indicated for the occlusion of the LAA under direct visualization, in conjunction with other open cardiac surgical procedures. The device is approved in the U.S. and the European Union, according Rastatt, Germany-based Maquet.

The implanted TigerPaw System II uses a single-use delivery tool and an implantable fastener to occlude the LAA during open chest procedures. “We believe TigerPaw II will be a best-in-class device for reliable ligation of the LAA, potentially mitigating post-operative stroke and its associated costs in patients with atrial fibrillation undergoing cardiac surgery,” Peter Hinchliffe, president and CEO for the Cardiac Surgery Business Unit of Maquet, said in a release.

LAAx is based in Livermore, Calif. Terms of the acquisition were not disclosed.

Candace Stuart, Contributor

Related Content

2 out of 5 AFib patients develop heart failure later in life
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
Biosense Webster takes key step toward FDA approval for Varipulse PFA system
Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system
Heart issues more common in adults who drink soda, other sweetened beverages

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup